この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. João N.に依頼
Netherlands
CRISPR & compound screening expert | Pre-clinical (in vitro and in vivo) drug validation expert
プロフィール概要
専門分野
サービス
Writing
Clinical Trial Documentation,
Technical Writing,
Newswriting
Research
Feasibility Study,
Fact Checking,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Data Visualization
Product Development
Formulation
職務経験
PhD student
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
9月 2015 - 現在 ![]()
学歴
Master of Science (Chemistry Department)
Universidade de Aveiro
9月 2013 - 7月 2015 ![]()
Bachelor of Science (Chemistry Department)
Universidade de Aveiro
9月 2010 - 6月 2014 ![]()
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
João M. Fernandes Neto, Ernest Nadal, Evert Bosdriesz, Salo N. Ooft, Lourdes Farre, Chelsea McLean, Sjoerd Klarenbeek, Anouk Jurgens, Hannes Hagen, Liqin Wang, et al. (2020). Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours . Nature Communications.
Wang, L., Leite de Oliveira, R., Wang, C., Fernandes Neto, J.M., Mainardi, S., Evers, B., Lieftink, C., Morris, B., Jochems, F., Willemsen, L., et al.(2017). High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer . Cell Reports. 21. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 773-783.
OTHER
João M. Fernandes Neto, Ernest Nadal, Salo N Ooft, Evert Bosdriesz, Lourdes Farre, Chelsea McLean, Sjoerd Klarenbeek, Anouk Jurgens, Hannes Hagen, Liqin Wang, et al.(2019). Multiple Low Dose ({MLD}) therapy: an effective strategy to treat {EGFR} inhibitor-resistant {NSCLC} tumours . Cold Spring Harbor Laboratory